PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-06 (4)

Date Title Company
06-Feb-2024 Vertex Announces Positive Results From Pivotal Trials of Vanzacaftor/Tezacaftor/Deutivacaftor, Next-In-Class Triple Combination Treatment for Cystic Fibrosis Businesswire